BC Cancer Foundation donors have propelled two exciting discoveries in lymphoma
BC Cancer Foundation donors have propelled lymphoma research forward, supporting the BC Cancer lymphoma team’s work and underpinning two exciting discoveries.
DISCOVERY REVEALS THAT HODGKIN LYMPHOMA HIJACKS PATIENT’S IMMUNE CELLS
BC Cancer researchers discovered key information about how Hodgkin lymphoma cells can grow undetected within the body, thanks to donor funded single cell genomics technology.
“Reviewing the complete tumour microenvironment is a critical component to better understanding how diseases adapt within the body and how we can better inform treatment decisions,” says Dr. Christian Steidl, associate vice president, research, BC Cancer.
These findings, published in December in Cancer Discovery, show the importance of being able to evaluate the dynamics between healthy and cancerous cells within a tumour microenvironment.
DISCOVERING TMEM30A: A GENE TO EXPLOIT IN THE QUEST FOR MORE CURES
A new breakthrough in diffuse large B-Cell lymphoma supports the future of breaking down cancer cells.
The TMEM30A gene harbours critical, and exploitable, abnormalities. It’s playing two interesting roles in the most common blood cancer, diffuse large B-cell lymphoma.
BC Cancer experts have linked the gene’s new-found behaviours to patients who have positive outcomes—an anomaly as gene mutations are typically linked to poor outcomes.